ConductScience.org, home

Paper7249508

A method for estimating the probability of adverse drug reactions.

Naranjo CA and 8 others. Clin Pharmacol Ther, 1981. Cited by 9,329 papers, by iCite.

Cite this record

ConductScience Library. A method for estimating the probability of adverse drug reactions. Papers, record 7249508. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7249508

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A method for estimating the probability of adverse drug reactions.
PubMed
Journal
Clin Pharmacol Ther
PubMed
Year
1981
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
9,329
iCite
Relative citation ratio, by iCite
366
iCite
Revised in PubMed
2025-10-27
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Naranjo CAC A
2Busto UU
3Sellers EME M
4Sandor PP
5Ruiz II
6Roberts EAE A
7Janecek EE
8Domecq CC
9Greenblatt DJD J

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Drug-Related Side Effects and Adverse ReactionsMajor topic
Evaluation Studies as Topic
Humans
Methods
Pharmacists
Physicians
Probability
Random Allocation

Source PubMed

Download CSV of topics

Trials9

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT00101868Value of Technology to Transfer Discharge InformationBackgroundClinicalTrials.gov
NCT01933984Individualized Dosing Schedule of Inhaled Bronchodilator for Endotracheally Intubated COPD PatientsBackgroundClinicalTrials.gov
NCT05002192A Retrospective, Real-world Study of ELP Used in the Expectorant Treatment of Community-acquired PneumoniaBackgroundClinicalTrials.gov
NCT05205746Phase II Study of AVX/COVID-12 Vaccine in Subjects With Prior SARS-CoV-2 Immunity EvidenceBackgroundClinicalTrials.gov
NCT05710783Phase II/III Study of the AVX/COVID-12 Vaccine Against COVID-19 Applied as a Booster.BackgroundClinicalTrials.gov
NCT05967871Pilot Feasibility Study of Fecal Microbiota Transplant for the Treatment of Small Intestinal Bacterial OvergrowthBackgroundClinicalTrials.gov
NCT06574789Individualised Dose Optimisation of Ganciclovir in Immunocompromised Children Trial (ID-MAGIC)BackgroundClinicalTrials.gov
NCT06918665HEALTH Trial - Healthy Adult Evaluation of Ivermectin Bioequivalence: Infant Versus Standard FormulationBackgroundClinicalTrials.gov
NCT06950138Efficacy of Triticum Aestivum Over Vascular Function in Mexican Obese PatientsBackgroundClinicalTrials.gov

Download CSV of trials

Cited by3,971

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9,329 citations.

PMIDTitleJournalYearIn PapersSource
42989382Amoxicillin-clavulanate-induced neurotoxicity in a patient with end-stage renal disease: a case of reversible encephalopathy.J Med Case Rep2026https://conductscience.org/library/papers/42989382PubMed
42979088Real‑World Evaluation of Omadacycline Switch Therapy for Multidrug‑Resistant Bacterial Pneumonia in Patients with Tigecycline Intolerance.Drug Des Devel Ther2026https://conductscience.org/library/papers/42979088PubMed
42978736Oral Adverse Drug Reactions in Patients Receiving Polypharmacy: A Prospective Interdisciplinary Case Series.Cureus2026https://conductscience.org/library/papers/42978736PubMed
42975779Clinical and forensic implications of severe liver injury associated with selective androgen receptor modulators and other performance-enhancing drugs advertised on social media.Wien Med Wochenschr2026https://conductscience.org/library/papers/42975779PubMed
42973824Subacute Thyroiditis Following Third Dose of Pfizer-BioNTech COVID-19 (mRNA) Vaccine in a Patient with Clear Cell Renal Cell Carcinoma: A Case Report.Oman Med J2026https://conductscience.org/library/papers/42973824PubMed
42968972Localized Morbilliform Drug Eruption Following Sildenafil Exposure: A Case Report.Cureus2026https://conductscience.org/library/papers/42968972PubMed
42964650Severe Thrombocytopenia Induced by Re-Exposure to Piperacillin/Tazobactam: A Case Report in Critically Ill Patient With COVID-19.Clin Case Rep2026https://conductscience.org/library/papers/42964650PubMed
42959829Trigger-first large language model-assisted adverse drug reaction surveillance: A pharmacist-supervised retrospective cohort study.Explor Res Clin Soc Pharm2026https://conductscience.org/library/papers/42959829PubMed
42951318Single-strength trimethoprim/sulfamethoxazole (TMP/SMX)-induced hypoglycaemia in a post kidney-pancreas transplant patient.BMJ Case Rep2026https://conductscience.org/library/papers/42951318PubMed
42948793Development and validation of a standardized causality assessment tool for adverse events associated with medical devices.Perspect Clin Res2026https://conductscience.org/library/papers/42948793PubMed
42947907Tislelizumab-induced immune-mediated hepatotoxicity combined with two episodes of hepatitis B virus reactivation: a case report.Front Pharmacol2026https://conductscience.org/library/papers/42947907PubMed
42946496Olmesartan-associated enteropathy presenting as severe malnutrition.BMJ Case Rep2026https://conductscience.org/library/papers/42946496PubMed
42941598Dasatinib-Associated Gastrointestinal Bleeding and Colitis: A Narrative Review with Illustrative Cases.J Clin Med2026https://conductscience.org/library/papers/42941598PubMed
42939334From Pharmacological Trigger to Manic State: Convergent Neurobiological Mechanisms of Drug-Induced Mania.Brain Sci2026https://conductscience.org/library/papers/42939334PubMed
42938118Antibiotic-Refractory Fever with Pyelonephritis-like Features Revealing Occult Metastatic High-Grade Serous Carcinoma: Competing Causes of Fever and Diagnostic Stewardship.Diagnostics (Basel)2026https://conductscience.org/library/papers/42938118PubMed
42936270Ischemic Colitis in the Setting of Tirzepatide Use: A Potentially Underrecognized Adverse Effect.Cureus2026https://conductscience.org/library/papers/42936270PubMed
42928934Ticagrelor-Induced Bradyarrhythmias in Acute Coronary Syndrome: A Case Series of Three Patients.Cureus2026https://conductscience.org/library/papers/42928934PubMed
42924238Lithium Carbonate as Treatment for Paliperidone Long-Acting Injection-Induced Leukopenia and Neutropenia in a Patient With Schizophrenia: A Case Report.Cureus2026https://conductscience.org/library/papers/42924238PubMed
42924066Cerebral Venous Thrombosis following Sacituzumab Govitecan in Metastatic Breast Cancer: A Case Report.Case Rep Oncol2026https://conductscience.org/library/papers/42924066PubMed
42924008Severe Intraocular Inflammation Mimicking Masquerade Syndrome in a Patient Treated with Dupilumab: A Case Report.Case Rep Ophthalmol2026https://conductscience.org/library/papers/42924008PubMed

See all 3,971 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7249508

GET https://conductscience.org/api/papers/v1/7249508/cited_by?page=2